Desq Long
Sign in

Company

Protagonist Therapeutics, Inc

PTGX · CIK 0001377121

SEC FORM 4
$359,746.42

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 9,229 shares at $38.98 per share.

Reporting Person Ali Asif · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001104659-26-113279 · filed 2026-10-02 · View filing →

SEC FORM 4
$666,017.96

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 28,438 shares at $23.42 per share.

Reporting Person Ali Asif · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001104659-26-113279 · filed 2026-10-02 · View filing →

SEC FORM 4
$300,323.50

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 15,650 shares at $19.19 per share.

Reporting Person Ali Asif · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001104659-26-113279 · filed 2026-10-02 · View filing →

SEC FORM 4
$64,647.04

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 5,312 shares at $12.17 per share.

Reporting Person Ali Asif · Officer Title Chief Financial Officer · Transaction Code M

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001104659-26-113279 · filed 2026-10-02 · View filing →

SEC FORM 4
$1,785,593.15

Protagonist Therapeutics, Inc (PTGX)

Sale of 12,595 shares at $141.77 per share.

Reporting Person Ali Asif · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001104659-26-113279 · filed 2026-10-02 · View filing →

SEC FORM 4
$6,526,700.52

Protagonist Therapeutics, Inc (PTGX)

Sale of 46,034 shares at $141.78 per share.

Reporting Person Ali Asif · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001104659-26-113279 · filed 2026-10-02 · View filing →

SEC FORM 4
$157,059.24

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 7,278 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Sep 10, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$1,048,759.80

Protagonist Therapeutics, Inc (PTGX)

Sale of 7,278 shares at $144.10 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$1,371,365.84

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 63,548 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$9,289,446.64

Protagonist Therapeutics, Inc (PTGX)

Sale of 63,548 shares at $146.18 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Sep 9, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$1,169,074.92

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 54,174 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$7,902,361.38

Protagonist Therapeutics, Inc (PTGX)

Sale of 54,174 shares at $145.87 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001104659-26-106831 · filed 2026-09-10 · View filing →

SEC FORM 4
$738,877.62

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 34,239 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095111 · filed 2026-08-12 · View filing →

SEC FORM 4
$5,085,176.28

Protagonist Therapeutics, Inc (PTGX)

Sale of 34,239 shares at $148.52 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095111 · filed 2026-08-12 · View filing →

SEC FORM 4
$1,419,122.38

Protagonist Therapeutics, Inc (PTGX)

Acquisition (code M) of 65,761 shares at $21.58 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code M

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095111 · filed 2026-08-12 · View filing →

SEC FORM 4
$9,805,622.71

Protagonist Therapeutics, Inc (PTGX)

Sale of 65,761 shares at $149.11 per share.

Reporting Person PATEL DINESH V PH D · Officer Title President and CEO · Transaction Code S

Traded Aug 10, 2026 · Disclosed Aug 12, 2026

Source: SEC Form 4 · 0001104659-26-095111 · filed 2026-08-12 · View filing →